Form D · Other Technology

Ekotrope, Inc.

Boston, MA · CIK 0001520975

Offering snapshot reported Oct 10, 2025 · SEC filing

Reported sold
$11M
Offering amount: $11M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 1, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 10, 2025Initial$11,000,000No comparison1SEC filing
May 23, 2017Initial$617,777No comparison16SEC filing
Dec 8, 2014Initial$1,355,042No comparison16SEC filing
Aug 5, 2013Initial$1,700,000No comparison2SEC filing
Jan 4, 2013Amendment$1,250,000$345,000vs Apr 10, 201217SEC filing
Apr 10, 2012Amendment$905,000$660,000vs May 17, 201113SEC filing
May 17, 2011Initial$245,000No comparison5SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-560481
The Total Offering Amount and Total Amount Sold includes $8,142,748.90 of preferred stock purchased and $2,857,251.10 of shares issued in connection with a secondary transaction.

Source: Form D, filed Oct 10, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Edward Crawley Director
Mark Johnson Director
Kenneth Lazarus Director
Emil Mamedov Director
Galen Nelson Director
Ziv Rozenblum Director, Executive
Alexander Turkot Director

Issuer details

Industry: Other Technology (See others in industry)

Address:
19 Kingston St. Level 3
Boston, MA, 02111